Literature DB >> 16049991

The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.

Hei-Jen Jou1, Yih-Shing Kuo, Jenn-Jeih Hsu, Ming-Kwang Shyu, T'sang-T'ang Hsieh, Fon-Jou Hsieh.   

Abstract

OBJECTIVES: The aim of the present study was to determine whether the liberal use of second-trimester maternal serum screening in Taiwan started in 1994 had a measurable impact on birth prevalence of infants with Down syndrome (DS) in the past decade.
METHODS: We based our study on the databases of 'National Birth Defect Registration and Notification System', 'Amniocentesis in Pregnant Women', and 'Demographic Fact Book' in Taiwan. Collected data included total registered birth number, the registered number of stillbirths, the registered numbers of live births and of DS stillbirths affected with DS, amniocentesis rates each year in pregnant women aged 35 or more, and the age distribution of pregnant women in Taiwan. The live birth rate of and total birth rate of fetuses affected with DS, and the rates of live birth and stillbirth to total birth with DS, were analyzed year by year, in order to understand the change of birth rate of infants affected with DS between 1993 and 2001. Those with isolated cleft palate (ICP) were also analyzed as internal control variable. Confidence interval of live birth rate of infants with DS under Poisson distribution was calculated. Chi-square test for trend in binomial proportions was performed to see if there is an increasing (or decreasing) trend in the proportion of incidence of fetuses affected with DS. The difference was statistically significant if a p value was <0.05.
RESULTS: A total of 1 331 616 deliveries were collected during the study period, including 840 cases of DS confirmed by karyotyping study. A marked decrease in the live birth rates of case with DS occurred in 1994-95, from 0.63 per 1000 births to 0.23 per 1000 births. There was a crossover from more live births with DS to more stillbirths with DS during 1994 to 1996 after the implementation of second-trimester maternal serum screening for DS in 1994. In 1993, 76.9% of births diagnosed with DS were born alive, compared to 32.5% in 2001 (p < 0.001).
CONCLUSIONS: The policy of prenatal diagnosis program including amniocentesis for pregnant women aged 35 or more and the liberal application of maternal serum screening for DS in younger women was responsible for the marked decrease in the live births affected with DS in Taiwan from 1993 to 2001. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16049991     DOI: 10.1002/pd.1220

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  10 in total

1.  The future of neo-eugenics. Now that many people approve the elimination of certain genetically defective fetuses, is society closer to screening all fetuses for all known mutations?

Authors:  Armand Marie Leroi
Journal:  EMBO Rep       Date:  2006-12       Impact factor: 8.807

2.  Development of genetic counseling services in Taiwan.

Authors:  Shu Chien; Pen-Hua Su; Suh-Jen Chen
Journal:  J Genet Couns       Date:  2013-04-18       Impact factor: 2.537

Review 3.  Down Syndrome Screening in India: Are We There Yet?

Authors:  K Manikandan; Suresh Seshadri
Journal:  J Obstet Gynaecol India       Date:  2017-08-17

4.  A population-based study of prevalence of Down syndrome in Southern Thailand.

Authors:  Somchit Jaruratanasirikul; Ounjai Kor-Anantakul; Montira Chowvichian; Wannee Limpitikul; Pathikan Dissaneevate; Nitthakarn Intharasangkanawin; Atchara Sattapanyo; Sermsri Pathompanitrat; H Sriplung
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

5.  The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia, 1996-2005: the impact of screening and amniocentesis.

Authors:  Bojana Brajenović-Milić; Igor Prpić; Oleg Petrović; Smiljana Ristić; Gordana Brumini; Miljenko Kapović
Journal:  Matern Child Health J       Date:  2007-08-22

6.  Postnatal Identification of Trisomy 21: An Overview of 7,133 Postnatal Trisomy 21 Cases Identified in a Diagnostic Reference Laboratory in China.

Authors:  Weiwei Zhao; Fan Chen; Menghua Wu; Shuai Jiang; Binbin Wu; Huali Luo; Jingyi Wen; Chaohui Hu; Shihui Yu
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

7.  Demographic Assessment of Down Syndrome: A Systematic Review.

Authors:  Agustín Huete-García; Mónica Otaola-Barranquero
Journal:  Int J Environ Res Public Health       Date:  2021-01-05       Impact factor: 3.390

8.  The impact of prenatal screening tests on prenatal diagnosis in Taiwan from 2006 to 2019: a regional cohort study.

Authors:  Ching Hua Hsiao; Ching Hsuan Chen; Po Jen Cheng; Steven W Shaw; Woei Chyn Chu; Ran Chou Chen
Journal:  BMC Pregnancy Childbirth       Date:  2022-01-09       Impact factor: 3.007

9.  The impact of Down syndrome screening on Taiwanese Down syndrome births: a nationwide retrospective study and a screening result from a single medical centre.

Authors:  Shin-Yu Lin; Chia-Jung Hsieh; Yi-Li Chen; S W Steven Shaw; Sheng-Wen Steven Shaw; Ming-Wei Lin; Pau-Chung Chen; Chien-Nan Lee
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 10.  Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?

Authors:  Melissa Hill; Angela Barrett; Mahesh Choolani; Celine Lewis; Jane Fisher; Lyn S Chitty
Journal:  Prenat Diagn       Date:  2017-12       Impact factor: 3.050

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.